ATC Group: S03AA07 Ciprofloxacin

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of S03AA07 in the ATC hierarchy

Level Code Title
1 S Sensory organs
2 S03 Ophthalmological and otological preparations
3 S03A Antiinfectives
4 S03AA Antiinfectives
5 S03AA07 Ciprofloxacin

Active ingredients in S03AA07

Active Ingredient Description
Ciprofloxacin

Ciprofloxacin is a fluoroquinolone antibacterial agent. The bactericidal action of ciprofloxacin results from the inhibition of both type II topoisomerase (DNA-gyrase) and topoisomerase IV, required for bacterial DNA replication, transcription, repair and recombination.

Related product monographs

Title Information Source Document Type  
CILOXAN Eye drops, solution Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
CILOXAN Ointment FDA, National Drug Code (US) MPI, US: SPL/Old
CILOXAN Ophthalmic solution FDA, National Drug Code (US) MPI, US: SPL/Old

Medicines in this ATC group

United States (US)

Australia (AU)

Austria (AT)

Brazil (BR)

Canada (CA)

Croatia (HR)

Cyprus (CY)

Ecuador (EC)

Estonia (EE)

France (FR)

Ireland (IE)

Israel (IL)

Lithuania (LT)

Malta (MT)

New Zealand (NZ)

Nigeria (NG)

Poland (PL)

Singapore (SG)

South Africa (ZA)

Tunisia (TN)

Turkey (TR)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.